Menu
Enrolling by invitation NCT07734337

Reconstruction by Thoracodorsal Artery Perforator Flap in Patients With Upper Body Soft Tissue Defects

No phase Interventional Reconstruction of Upper Body Soft Tissue Defects

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Reconstruction.
Who it may be relevant to
Registry conditions: Reconstruction of Upper Body Soft Tissue Defects. Basic parameters: 5 years — 75 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Reconstructive Potential of The Pedicled Thoracodorsal Artery Perforator Flap; Prospective Clinical Assessment of The Arc of Rotation and Recipient-Site Reach in Upper Body Reconstruction

Overview

evaluation of versatility and reliability of thoracodorsal artery perforator flap by assessment of recipient site reach

Detailed description

Prospectively evaluate the reconstructive capacity of the pedicled thoracodorsal artery perforator (TDAP) flap by objectively measuring its arc of rotation and achievable recipient-site reach, and correlating these parameters with flap survival, complication rates, donor-site morbidity, and functional and aesthetic outcomes in upper body reconstruction.

Interventions

  • Procedure Reconstruction
    Harvesting thoracodorsal artery perforator flap and insetting in the recipient sites reachable for this flap

Primary outcome measures

  • Recipient Site Reach [Time frame: 12 months recruitment and 6 months follow up]

Eligibility criteria

Inclusion criteria

  • Patients aged 5 to 75 years old
  • Both sexes
  • Requiring upper body soft tissue reconstruction (e.g. breast, shoulder chest wall, axilla) following oncological resection, trauma, or contracture excision
  • Adequate general condition for surgery

Exclusion criteria

  • Patients with uncontrolled comorbidities.
  • Prior surgery or radiation in the donor region that compromises vascular anatomy.
  • Active local infection or poor wound bed vascularity.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Sohag University — Sohag

Identifiers

NCT: NCT07734337 · Soh-Med-26-6-1MS

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗